OUTLOOK THERAPEUTICS, INC. Share Price Nasdaq
Equities
US68235M1053
Biotechnology & Medical Research
Sales 2024 * | 204K 16.24M | Sales 2025 * | 11.85M 945M | Capitalization | 198M 15.79B |
---|---|---|---|---|---|
Net income 2024 * | -72M -5.74B | Net income 2025 * | -62M -4.94B | EV / Sales 2024 * | 972 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 16.7 x |
P/E ratio 2024 * |
-2.55
x | P/E ratio 2025 * |
-3.65
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.15% |
Latest transcript on OUTLOOK THERAPEUTICS, INC.
Managers | Title | Age | Since |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 06/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 14/09/15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 18/01/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 12/04/18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 10/12/15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 06/07/21 |
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |